BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15075004)

  • 21. The relationship between cyclooxygenase-2 expression and colorectal cancer.
    Sheehan KM; Sheahan K; O'Donoghue DP; MacSweeney F; Conroy RM; Fitzgerald DJ; Murray FE
    JAMA; 1999 Oct; 282(13):1254-7. PubMed ID: 10517428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human esophageal mucosa, dysplasia and carcinoma.
    Kase S; Osaki M; Honjo S; Hashimoto K; Adachi H; Tsujitani S; Ito H
    Pathobiology; 2004; 71(2):84-92. PubMed ID: 14707443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients.
    Masunaga R; Kohno H; Dhar DK; Ohno S; Shibakita M; Kinugasa S; Yoshimura H; Tachibana M; Kubota H; Nagasue N
    Clin Cancer Res; 2000 Oct; 6(10):4064-8. PubMed ID: 11051257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
    Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS
    Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of cyclooxygenase-2 in colorectal cancer and its clinical significance.
    Xiong B; Sun TJ; Hu WD; Cheng FL; Mao M; Zhou YF
    World J Gastroenterol; 2005 Feb; 11(8):1105-8. PubMed ID: 15754389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of cyclooxygenase-2 in malignant pheochromocytomas.
    Salmenkivi K; Haglund C; Ristimäki A; Arola J; Heikkilä P
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5615-9. PubMed ID: 11701743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variation in cyclooxygenase expression levels within the colorectum.
    Wiese FW; Thompson PA; Warneke J; Einspahr J; Alberts DS; Kadlubar FF
    Mol Carcinog; 2003 May; 37(1):25-31. PubMed ID: 12720297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EP1-4 subtype, COX and PPAR gamma receptor expression in colorectal cancer in prediction of disease-specific mortality.
    Gustafsson A; Hansson E; Kressner U; Nordgren S; Andersson M; Wang W; Lönnroth C; Lundholm K
    Int J Cancer; 2007 Jul; 121(2):232-40. PubMed ID: 17290397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas.
    Okami J; Yamamoto H; Fujiwara Y; Tsujie M; Kondo M; Noura S; Oshima S; Nagano H; Dono K; Umeshita K; Ishikawa O; Sakon M; Matsuura N; Nakamori S; Monden M
    Clin Cancer Res; 1999 Aug; 5(8):2018-24. PubMed ID: 10473081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic importance of COX-2 expression in patients with colorectal cancer.
    Yamac D; Celenkoglu G; Coskun U; Akyurek N; Akcali Z; Dursun A; Koybasioglu F
    Pathol Res Pract; 2005; 201(7):497-502. PubMed ID: 16164044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of cyclo-oxygenase 2 in squamous cell carcinoma of the hypopharynx.
    Peng JP; Su CY; Chang HC; Chai CY; Hung WC
    Hum Pathol; 2002 Jan; 33(1):100-4. PubMed ID: 11823979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclooxygenase-2 expression in oral squamous cell carcinoma.
    Pannone G; Bufo P; Caiaffa MF; Serpico R; Lanza A; Lo Muzio L; Rubini C; Staibano S; Petruzzi M; De Benedictis M; Tursi A; De Rosa G; Macchia L
    Int J Immunopathol Pharmacol; 2004; 17(3):273-82. PubMed ID: 15461861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.
    Eberhart CE; Coffey RJ; Radhika A; Giardiello FM; Ferrenbach S; DuBois RN
    Gastroenterology; 1994 Oct; 107(4):1183-8. PubMed ID: 7926468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis of colorectal cancer - role of gastrin and cyclooxygenase-2.
    Hartwich J; Konturek SJ; Pierzchalski P; Zuchowicz M; Konturek PC; Bielański W; Marlicz K; Starzyńska T; Ławniczak M
    Med Sci Monit; 2001; 7(6):1171-81. PubMed ID: 11687726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear factor-kappa B regulates cyclooxygenase-2 expression and cell proliferation in human colorectal carcinoma tissue.
    Yu LL; Yu HG; Yu JP; Luo HS
    Eksp Onkol; 2004 Mar; 26(1):40-7. PubMed ID: 15112579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis.
    Nosho K; Yoshida M; Yamamoto H; Taniguchi H; Adachi Y; Mikami M; Hinoda Y; Imai K
    Carcinogenesis; 2005 May; 26(5):892-9. PubMed ID: 15695237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention.
    Reddy BS; Hirose Y; Cohen LA; Simi B; Cooma I; Rao CV
    Cancer Res; 2000 Sep; 60(17):4792-7. PubMed ID: 10987288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between COX-2 expression and clinicopathological features of colorectal cancers.
    Zhan J; Liu JP; Zhu ZH; Yao HR; Chen CY
    Chin Med J (Engl); 2004 Aug; 117(8):1151-4. PubMed ID: 15361286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
    Koga H; Sakisaka S; Ohishi M; Kawaguchi T; Taniguchi E; Sasatomi K; Harada M; Kusaba T; Tanaka M; Kimura R; Nakashima Y; Nakashima O; Kojiro M; Kurohiji T; Sata M
    Hepatology; 1999 Mar; 29(3):688-96. PubMed ID: 10051469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
    Zhan J; Tang XD
    Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.